Methicillin-resistant staphylococcus aureus in surgical patients: Identification of high-risk populations for the development of targeted screening programmes

Annals of the Royal College of Surgeons of England

Volumn 92, Issue 4, 2010, Pages 311-315

  Fraser, Stephanie ^a   Brady, Richard R ^b   Graham, Catriona ^c   Paterson Brown, Simon ^a   Gibb, Alan P ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cancer; Hospital acquired infection; MRSA; Outcomes; Screening; Surgery

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CROSS INFECTION; DISEASE TRANSMISSION; EPIDEMIOLOGY; FEMALE; HUMAN; INTENSIVE CARE; ISOLATION AND PURIFICATION; LENGTH OF STAY; MALE; MASS SCREENING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 77953627207     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588410X12628812459698     Document Type: Article

References (29)

1. Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N et al.; European Antimicrobial Resistance Surveillance System Participants. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-1634.
2. Reilly JS, Allardice G, Noone A, Robertson C, Walker A, Coubrough F. Microbiology. In: NHS Scotland National Prevalence Study: volume 1 of 2. Glasgow: Health Protection Scotland, 2007; 205-216
3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59
4. Health Protection Agency. Summary points and commentary on Quarterly (April 2006 to September 2008), six monthly (April 2001 to September 2008) and financial year (April 2001 to March 2008) MRSA bacteraemia data derived from Mandatory Surveillance. December 2008. [accessed 6 January 2009].
5. Coia JE, Duckworth GJ, Edwards DI, Farrington M. Fry C, Humphreys H et al. Joint Working Party of the British Society of Antimicrobial Chemotherapy; Hospital Infection Society; Infection Control Nurses Association.. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63 (Suppl 1): S1-44.
6. Health Protection Scotland. MRSA screening programme. eWeekly Report 2008 42(23). [accessed 6 January 2009].
7. Dancer SJ. Considering the introduction of universal MRSA screening. J Hosp Infect 2008; 69: 315-320
8. MacKenzie R, Nimmo F, Bachoo P, Alozairi O, Brittenden J. The relationship between socio-economic status, geography, symptomatic carotid territory disease and carotid endarterectomy. Eur J Vasc Endovasc Surg 2003; 28: 145-149
9. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006; 333: 281.
10. European Antimicrobial Resistance Surveillance System. Annual Report 2005: Ongoing surveillance of S. pneumoniae, S. aureus, E. faecalis, E. faecium, E. coil, K. pneumoniae and P. aeruginosa. Bilthoven: RIVM EARSS, 2005.
11. Ritchie K, Craig J, Eastgate J et al. The clinical and cost effectiveness of screening for meticillin-resistant Staphylococcus aureus (MRSA). Glasgow: NHS Quality Improvement Scotland Health Technology Assessment Report 9, 2007.
12. Watters K, O'Dwyer TP, Rowley H. Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences? J Laryngol Otol 2004; 118: 694-699
13. Wang FD, Chen YY, Chen TL, Liu CY. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Am J Infect Control 2008; 36: 118-122
14. Suda KJ, Motl SE, Kuth JC. Inpatient oncology length of stay and hospital costs: Implications for rising inpatient expenditures. J Appl Res 2006; 6: 126-131
15. Ripamonti CI, Farina G, Garassino MC. Predictive models in palliative care. Cancer 2009; 115 (Suppl): 3128-3134
16. Seve P, Ray-Coquard I, Trillet-Lenoir V, Sawyer M, Hanson J, Broussolle C et al. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer 2006; 107: 2698-2705
17. Saito T, Kinoshita T, Shigemitsu Y, Katsuta T, Shimoda K, Kobayashi M. IgG2 deficiency in methicillin-resistant Staphylococcus aureus infections after esophageal surgery. Surg Today 1994; 24: 187-188
18. Ozawa S, Kitagawa Y, Okamoto N, Shimizu Y, Kitajima M. [Infectious complications after esophageal surgery.] Nippon Geka Gakkai Zasshi 2002; 103: 865-868
19. Uchiyama K, Takifuji K, Tani M, Ueno M, Kawai M, Ozawa S et al. Prevention of postoperative infections by administration of antimicrobial agents immediately before surgery for patients with gastrointestinal cancers. Hepatogastroenterology 2007; 54: 1487-1493
20. Tacconelli E, Pop-Vicas AE, D'Agata EM. Increased mortality among elderly patients with meticillin-resistant Staphylococcus aureus bacteraemia. J Hosp Infect 2006; 64: 251-256
21. McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 2004; 25: 461-467
22. Beam JW, Buckley B. Community-acquired methicillin-resistant Staphylococcus aureus: prevalence and risk factors. J Athl Train 2006; 41: 337-340
23. Haddadin AS, Fappiano SA, Lipsett PA. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J 2002; 78: 385-392
24. DeRyke CA, Lodise Jr TP, Rybak MJ, McKinnon PS. Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 2005; 128: 1414-1422
25. Abraham J, Mansour C, Veledar E, Khan B, Lerakis S. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S. aureus and methicillin-resistant S. aureus bacteremia. Am Heart J 2004; 147: 536-539
26. Bamberger DM, Boyd SE. Management of Staphylococcus aureus infections. Am Fam Phys 2005; 72: 2474-2481
27. Lu PL, Chin LC, Peng CF, Chiang YH, Chen TP, Ma L et al. Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J Clin Microbiol 2005; 43: 132-139
28. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26: 166-174
29. Marshall C, Harrington G, Wolfe R, Fairley CK, Wesselingh S, Spelman D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 2003; 24: 322-326